For breast cancer cases with positive hormone receptors (n=680 cases), a higher BMI contributed to a PAF of 19.9% (95% CI 9.1% to 27.8%) while with CUN-BAE, PAF was 41.9% (95% CI 26.3% to 61.2%). This evidence concerns the gene NR4A1 and breast carcinoma.